Comella, P., Massidda, B., Natale, D., Putzu, C., Sandomenico, C., Filippelli, G., et al. (2011). Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience. CLINICAL COLORECTAL CANCER, 10 (1), 42-47.
Data di pubblicazione: | 2011 |
Titolo: | Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience |
Autori: | |
Citazione: | Comella, P., Massidda, B., Natale, D., Putzu, C., Sandomenico, C., Filippelli, G., et al. (2011). Efficacy and tolerability of biweekly bevacizumab, irinotecan, folinic acid and fluorouracil intravenous bolus (BIFF Regimen) in patients with metastatic colorectal cancer: the southern Italy cooperative oncology group experience. CLINICAL COLORECTAL CANCER, 10 (1), 42-47. |
Rivista: | |
Appare nelle tipologie: | 1.01 Articolo in rivista |
File in questo prodotto:
File | Descrizione | Tipologia | Licenza | |
---|---|---|---|---|
BIFF (Clin Colorectal Cancer 2011) phase II trial.pdf | N/A | Administrator Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.